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Changes in the intracellular concentrations of Ca2þ and Mg2þ play a significant
role in cell growth and differentiation. Mesenchymal stem cells (MSCs) from
bone marrow are a potential source for tissue repair due to their ability to dif-
ferentiate into specialized cells, including bone, fat and muscle. However, the
molecular signals controlling the differentiation process remains largely un-
known. In this study, we examined whether MSCs express Transient Receptor
Potential Melastatin 7 (TRPM7), a member of the TRP family of ion channels
and a key pathway for Ca2þ and Mg2þ entry into cells. By RT-PCR, we iden-
tified TRPM7 transcripts with the expected molecular size of 198bp, but not
TRPM6 (317bp), a close family member with similar function. Electrophysio-
logical recordings revealed that depletion of intracellular Mg2þ or Mg2þ-ATP
activated TRPM7, suggesting that the channel is functionally active. Further-
more, treatment of MSCs with 2-aminoethoxydiphenyl borate (2-APB 1pM-
100mM), a TRPM7 blocker inhibited TRPM7 currents in a dose-dependent
manner. Our findings suggest that TRPM7 may represent an important pathway
for controlling stem cell growth and differentiation by regulating the amount of
Ca2þ and Mg2þ entering cells.
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TRPML1 (mucolipin-1/MCOLN1) is predicted to be an intracellular late endo-
somal and lysosomal ion channel protein belonging to the mucolipin subfamily
of Transient Receptor Potential (TRP) proteins. Mutations in the human
TRPML1 gene cause mucolipidosis type IV disease (ML4). ML4 patients
exhibit motor impairment, mental retardation, retinal degeneration, and iron-de-
ficiency anemia. Since aberrant iron metabolism may cause neural and retinal
degeneration, itmay be a primary cause ofML4phenotypes. Inmostmammalian
cells, release of iron from endosomes and lysosomes following iron uptake via
endocytosis of Fe3þ-bound transferrin receptors, or following lysosomal degra-
dation of ferritin-Fe complexes and autophagic ingestion of iron-containing
macromolecules, is the major source of cellular iron. The Divalent Metal Trans-
porter protein (DMT1) is the only endosomal Fe2þ transporter currently known
and is highly expressed in erythroid precursors, but genetic studies suggest the
existence of a DMT1-independent endosomal/lysosomal Fe2þ transport protein.
Here, by measuring radiolabeled iron uptake, monitoring the levels of cytosolic
and intra-lysosomal iron and directly patch-clamping the late endosomal/lyso-
somalmembrane, we show that TRPML1 functions as a Fe2þ permeable channel
in late endosomes and lysosomes. ML4 mutations are shown to impair
TRPML1’s ability to permeate Fe2þ at varying degrees, which correlate well
with the disease severity. A comparison of TRPML1/ ML4 and control skin
fibroblasts showed a reduction of cytosolic Fe2þ levels, an increase of intra-
lysosomal Fe2þ levels, and an accumulation of lipofuscin-like molecules in
TRPML1/ cells. We propose that TRPML1 mediates a mechanism by which
Fe2þ is released from late endosomes/lysosomes. Our results suggest that im-
paired iron transport may contribute to both hematological and degenerative
symptoms of ML4 patients.
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The mucolipin TRP (TRPML) proteins are a family of intracellular channels
primarily localized in the late endosome and lysosome. Mutations in the human
TRPML1 gene cause mucolipidosis type IV disease, a devastating pediatricneurodegenerative disease. In wild-type TRPML1-expressing HEK293 cells,
no significant channel activity can be detected at the plasma membrane, but
a proline substitution (TRPML1V432P) results in a large whole-cell current
that allows characterization of TRPML1 as a Ca2þ and Fe2þ/Mn2þ dually
permeable channel. As TRPML1-mediated current can be recorded in late
endolysosom using our recently developed lysosome patch-clamp technique,
it remains unknown whether large TRPML1V432Pmediated current has resulted
from increased surface expression (‘‘trafficking’’ effect), increased constitutive
channel activity (‘‘gating’’ effect), or both. In the current study, we systemat-
ically but individually performed the proline substitutions on 20 amino acid res-
idues around the 432 spot, a S4-S5 linker region. These proline-substitutions
were studied by whole-cell and lysosome lumenal-side-out recordings in
TRPML1-expressing HEK293 cells. Several proline substitutions were identi-
fied to display gain-of-function (GOF) constitutive activity at both the plasma
membrane and endolysosomal membranes, and their localizations were not
restricted to late endosomes and lysosomes, while wild-type TRPML1 and
non-GOF substitutions were localized exclusively in these compartments. All
of the proline-substituted GOF TRPML1 channels displayed inwardly rectify-
ing currents that were carried by Ca2þ or Fe2þ/Mn2þ, but not protons. As lyso-
somal exocytosis is known to be Ca2þ-dependent, constitutive Ca2þ permeabil-
ity of proline substitutions may have resulted in stimulus-independent
intralysosomal Ca2þ release, hence the surface expression and whole-cell
current of TRPML1. We conclude that the TRPML1 channel is an inwardly
rectifying proton-impermeable cation-permeable channel, which may be gated
through unknown cellular mechanisms through a conformational change in the
cytoplasmic face of the TM5.
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TRPML3 is a Ca2þ channel expressed in intracellular vesicular compartments
and is regulated by Hþ that interact with the large intravesicular loop between
transmembrane domains 1 and 2. The A419P mutation in TRPML3 causes the
varitint-waddler phenotype as a result of gain-of-function (GOF). The mecha-
nism by which the A419P mutation leads to GOF is unknown. Here, we show
that the TRPML3 pore is dynamic and expands when conducting Ca2þ to
change its permeability and selectivity from a strong to a weak field strength
site. Pore expansion appears to be regulated by trapping Ca2þ, probably within
the pore. Expansion of the pore can be reversed only by conducting Naþ
through the pore. The A419Pmutation, which locks the channel in an open state
results in permanently expanded pore. Notably, the TRPML3(H283A) muta-
tion that eliminates regulation of TRPML3 by Hþ and locks the channel in
an open state shows the same pore properties as wild-type TRPML3. On the
other hand, the pore mutation E449A also locks the channel in an open state
and permanently expanded pore. Interestingly, the TRPML3 large intravesicu-
lar loop interacts with the pore domain composed of transmembranes 5 and 6.
Although this interaction is enhanced by the A419P and E449A mutations, it
is not affected by the loop mutation H283A, suggesting that pore expansion
together with enhanced loop-pore communication is responsible for the GOF.
Thesefindings provide amolecularmechanismforGOFby theTRPML3(A419P)
mutation to account for the varitint-waddler disease phenotype.
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 Polycystin-2 (PC2, TRPP2) is a member of the TRP (transient receptor poten-
tial) superfamily of cation channels. Like other members of this superfamily,
PC2 permeates Ca2þ, which is involved in both signal transduction, and
Ca2þ entry. Previously, we showed that PC2 is normally active at intracellu-
larly high Ca2þ concentrations (10-15 mM). Little is known, however, about
the role intracellular Ca2þ plays in PC2 channel function. Here, we explored
the role of physiological concentrations of intracellular Ca2þ in PC2-mediated
channel function in reconstituted apical membranes from term human syncytio-
trophoblast (hST). Addition of either EGTA (1 mM) or BAPTA (2 mM) to
reach low intracellular Ca2þ (<5 nM) at the cytoplasmic side, elicited a com-
plete PC2 channel inhibition. A dose response elicited by addition of increasing
cytoplasmic Ca2þ showed that Ca2þ activated PC2 with an apparent half
activating concentration of 4.78 nM and a Hill coefficient of ~5. Conversely,
extracellular Ca2þ concentrations, between 0.5 mM and 5 mM, had a stimula-
tory effect on PC2 channel activity while higher external concentrations
